Schneider Eugene - Insider Non-Derivative Transactions at IONIS PHARMACEUTICALS INC (IONS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 2, 2024, Schneider Eugene's relationship to IONIS PHARMACEUTICALS INC (IONS) is Officer (EVP, Chf Clinical Develop Ofcr), and currently has 49,812 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other IONS insiders.
Data Source: SEC.
Schneider Eugene - Insider Non-Derivative Transactions of IONS Common Stock
Schneider Eugene - Insider Non-Derivative Transactions at IONS
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Feb 3, 2024 | Sell -- (Common Stock) | 2106 | 49.59 | 47659 |
Feb 3, 2024 | Sell -- (Common Stock) | 2071 | 49.59 | 49812 |
Feb 2, 2024 | Acquisition -- (Common Stock) | 4033 | 0 | 51883 |
Jan 18, 2024 | Sell -- (Common Stock) | 5482 | 50.42 | 47850 |
Jan 17, 2024 | M -- (Common Stock) | 15162 | 0 | 53332 |
Jan 13, 2024 | Sell -- (Common Stock) | 8000 | 53.5 | 38170 |
Jan 13, 2024 | M -- (Common Stock) | 8000 | 32.6 | 46170 |
Dec 27, 2023 | Sell -- (Common Stock) | 25000 | 51.46 | 36052 |
Dec 27, 2023 | M -- (Common Stock) | 25000 | 47.34 | 61052 |
Feb 7, 2023 | Sell -- (Common Stock) | 1413 | 40.67 | 24946 |
Feb 4, 2023 | Acquisition -- (Common Stock) | 4033 | 0 | 26359 |
Jan 19, 2023 | Sell -- (Common Stock) | 4752 | 39.57 | 22326 |
Jan 18, 2023 | M -- (Common Stock) | 13046 | 0 | 27078 |